Federal grants to Cytonus Therapeutics Inc.
Cytonus Therapeutics Inc. in Columbus, Ohio received $3.1 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cancer Treatment Research, with $2.0 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.1 million
- Awards4
- Awarded in FY 2025$0
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.1 million |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $1.1 million |
| FY 2024 | 1 | $893,673 |
| FY 2025 | 0 | $0 |
Programs that fund Cytonus Therapeutics Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 1 | $2.0 million |
| Cardiovascular Diseases Research | 2 | $752,528 |
| National Center for Advancing Translational Sciences | 1 | $324,986 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $3.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Development of CA-IL-12 for triple negative breast cancer - most cancer patients die as a result of metastatic disease and our inability to effectively deliver therapeutic drugs into the anatomical niches where cancer cells thrive. Thus, there is a major unmet need to develop therapeutic strategies | Cancer Treatment Research | August 31, 2023 | $2.0 million |
| Therapeutic platform to treat disease lung using enucleated mesenchymal stem CELLS0/01/2021 - there is critical need for cell-based therapeutics that can be administered intravenously (IV), and effectively home to and deliver therapeutics to the respiratory system, while maintaining patient safety. | Cardiovascular Diseases Research | July 17, 2021 | $454,975 |
| Bioengineering a novel therapeutic transporter that crosses the blood brain barrier to treat brain disorders - while the brain blood barrier (BBB) is an important physiological barrier that protects the brain, it is also represents a formable barrier to therapeutic delivery. Therefore, there is a cr | National Center for Advancing Translational Sciences | August 20, 2021 | $324,986 |
| Targeted therapeutic delivery to diseased lungs using enucleated mesenchymal stem cells - there is critical need for cell-based therapeutics that can be administered intravenously (IV), and effectively home to and deliver therapeutics to the respiratory system, while maintaining patient safety. Cyto | Cardiovascular Diseases Research | September 20, 2021 | $297,553 |
Questions people ask
How much federal grant money does Cytonus Therapeutics Inc. get?
$3.1 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Cytonus Therapeutics Inc. the most?
The Department of Health and Human Services, with $3.1 million in 4 awards.
What is Cytonus Therapeutics Inc.'s largest federal grant?
$2.0 million under Cancer Treatment Research, with its first action in the period on August 31, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Cytonus Therapeutics Inc.?
Its largest are Cancer Treatment Research, Cardiovascular Diseases Research and National Center for Advancing Translational Sciences.
Other grant recipients in Columbus
- Ohio Department of Medicaid
- Ohio Department of Education
- Ohio Department of Job & Family Services
- Ohio Department of Transportation
- Ohio Department of Development
- Ohio Department of Health
- The Ohio State University
- The State of Ohio Office of Budget and Management
Largest federal grant recipients in Ohio · Federal grants in Ohio